메뉴 건너뛰기




Volumn 28, Issue 3, 2008, Pages 345-347

Risperidone treatment of borderline personality disorder assessed by a borderline personality disorder-specific outcome measure: A pilot study

Author keywords

[No Author keywords available]

Indexed keywords

RISPERIDONE; NEUROLEPTIC AGENT;

EID: 51449121218     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e318173083e     Document Type: Letter
Times cited : (11)

References (5)
  • 1
    • 33751116553 scopus 로고    scopus 로고
    • Efficacy of quetiapine monotherapy in bipolar I and II depression: A double-blind, placebocontrolled study (the BOLDER II study)
    • Thase ME, Macfadden W, Weisler RH, et al. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebocontrolled study (the BOLDER II study). J Clin Psychopharmacol. 2006;26:600-609.
    • (2006) J Clin Psychopharmacol , vol.26 , pp. 600-609
    • Thase, M.E.1    Macfadden, W.2    Weisler, R.H.3
  • 2
    • 10744220918 scopus 로고    scopus 로고
    • Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression
    • Tohen M, Vieta E, Calabrese J, et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry. 2003;60:1079-1088.
    • (2003) Arch Gen Psychiatry , vol.60 , pp. 1079-1088
    • Tohen, M.1    Vieta, E.2    Calabrese, J.3
  • 3
    • 0026567394 scopus 로고
    • Clinical trials in psychiatry: Should protocol deviation censor patient data?
    • Lavori PW. Clinical trials in psychiatry: should protocol deviation censor patient data? Neuropsychopharmacology. 1992;6:39-48.
    • (1992) Neuropsychopharmacology , vol.6 , pp. 39-48
    • Lavori, P.W.1
  • 4
    • 12944268752 scopus 로고    scopus 로고
    • The efficacy of duloxetine: A comprehensive summary of results from MMRM and LOCF- ANCOVA in eight clinical trials
    • Mallinckrodt CH, Raskin J, Wohlreich MM, et al. The efficacy of duloxetine: a comprehensive summary of results from MMRM and LOCF- ANCOVA in eight clinical trials. BMC Psychiatry. 2004;4:26.
    • (2004) BMC Psychiatry , vol.4 , pp. 26
    • Mallinckrodt, C.H.1    Raskin, J.2    Wohlreich, M.M.3
  • 5
    • 39849093340 scopus 로고    scopus 로고
    • Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration
    • Kirsch I, Deacon BJ, Huedo-Medina TB, et al. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med. 2008;5:e45.
    • (2008) PLoS Med , vol.5
    • Kirsch, I.1    Deacon, B.J.2    Huedo-Medina, T.B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.